NO175858B - - Google Patents

Download PDF

Info

Publication number: NO175858B
Authority: NO; Norway
Prior art keywords: bis; triiodo; acid; anilide; dihydroxy
Prior art date: 1987-11-16

Application number

NO885093A

Other languages

English (en)

Norwegian (no)

Other versions

NO885093L (no

NO885093D0 (no

NO175858C (no

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-11-16

Filing date

1988-11-15

Publication date

1994-09-12

1988-11-15 Application filed by Schering Ag filed Critical Schering Ag

1988-11-15 Publication of NO885093D0 publication Critical patent/NO885093D0/no

1989-05-18 Publication of NO885093L publication Critical patent/NO885093L/no

1994-09-12 Publication of NO175858B publication Critical patent/NO175858B/no

1994-12-21 Publication of NO175858C publication Critical patent/NO175858C/no

Links

239000002872 contrast media Substances 0.000 claims abstract description 25
125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 11
239000000126 substance Substances 0.000 claims abstract description 8
150000001990 dicarboxylic acid derivatives Chemical class 0.000 claims abstract description 3
-1 hydroxymalonic acid-bis[3,5-bis(2,3-dihydroxy-propyl-carbamoyl)-2,4,6-triiodo-anilide] hydroxymalonic acid-bis[3,5-bis(2,3-dihydroxy-N-methyl-propylcarbamoyl)-2,4,6-triiodo-anilide] Chemical compound 0.000 claims description 28
150000001875 compounds Chemical class 0.000 claims description 22
125000000217 alkyl group Chemical group 0.000 claims description 7
125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
OTIHCVLLJJLQAC-UHFFFAOYSA-N N,N'-bis[3,5-bis(1,3-dihydroxypropan-2-yl)-2,4,6-triiodophenyl]-2,3-dihydroxy-N,N'-dimethylbutanediamide Chemical compound OCC(CO)C=1C(=C(N(C(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(CO)CO)I)C(CO)CO)I)C)O)O)=O)C)C(=C(C=1I)C(CO)CO)I)I OTIHCVLLJJLQAC-UHFFFAOYSA-N 0.000 claims description 2
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
150000008040 ionic compounds Chemical class 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 51
239000000243 solution Substances 0.000 description 34
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 29
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
239000002244 precipitate Substances 0.000 description 18
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
150000002500 ions Chemical class 0.000 description 14
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
239000000047 product Substances 0.000 description 13
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
239000002253 acid Substances 0.000 description 11
125000002887 hydroxy group Chemical group [H]O* 0.000 description 11
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
235000011121 sodium hydroxide Nutrition 0.000 description 9
239000007787 solid Substances 0.000 description 8
230000035484 reaction time Effects 0.000 description 7
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
239000000706 filtrate Substances 0.000 description 6
239000011541 reaction mixture Substances 0.000 description 6
239000011734 sodium Substances 0.000 description 6
229910052708 sodium Inorganic materials 0.000 description 6
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
GOVTYORLXYFHQU-UHFFFAOYSA-N ClC(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(=O)Cl)I)C(=O)Cl)I)C)OC(C)=O)=O)C)C(=C(C=1I)C(=O)Cl)I)I Chemical compound ClC(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(=O)Cl)I)C(=O)Cl)I)C)OC(C)=O)=O)C)C(=C(C=1I)C(=O)Cl)I)I GOVTYORLXYFHQU-UHFFFAOYSA-N 0.000 description 5
BOHQDBIJOBSJND-UHFFFAOYSA-N [1,3-bis(3,5-dicarbonochloridoyl-2,4,6-triiodoanilino)-1,3-dioxopropan-2-yl] acetate Chemical compound ClC(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(=O)Cl)I)C(=O)Cl)I)OC(C)=O)=O)C(=C(C=1I)C(=O)Cl)I)I BOHQDBIJOBSJND-UHFFFAOYSA-N 0.000 description 5
125000004432 carbon atom Chemical group C* 0.000 description 5
229940039231 contrast media Drugs 0.000 description 5
239000011630 iodine Substances 0.000 description 5
229910052740 iodine Inorganic materials 0.000 description 5
238000000034 method Methods 0.000 description 5
239000000203 mixture Substances 0.000 description 5
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
TZEBLZRSPJJCOS-UHFFFAOYSA-N 2,4,6-triiodo-5-(methylamino)benzene-1,3-dicarbonyl chloride Chemical compound CNC1=C(I)C(C(Cl)=O)=C(I)C(C(Cl)=O)=C1I TZEBLZRSPJJCOS-UHFFFAOYSA-N 0.000 description 4
FBJVWRITWDYUAC-UHFFFAOYSA-N 5-amino-2,4,6-triiodobenzene-1,3-dicarbonyl chloride Chemical compound NC1=C(I)C(C(Cl)=O)=C(I)C(C(Cl)=O)=C1I FBJVWRITWDYUAC-UHFFFAOYSA-N 0.000 description 4
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
239000008280 blood Substances 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
150000002148 esters Chemical group 0.000 description 4
BHIBLUDGCVIIBS-UHFFFAOYSA-N 5-[[3-(3,5-dicarbonochloridoyl-2,4,6-triiodoanilino)-2-methoxy-3-oxopropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(=O)Cl)I)C(=O)Cl)I)OC)=O)C(=C(C=1I)C(=O)Cl)I)I BHIBLUDGCVIIBS-UHFFFAOYSA-N 0.000 description 3
AJJNAAOMSHXOKI-UHFFFAOYSA-N 5-[[3-[3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodo-N-methylanilino]-2-methoxy-3-oxopropanoyl]-methylamino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OC(CNC(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(NCC(CO)O)=O)I)C(NCC(CO)O)=O)I)C)OC)=O)C)C(=C(C=1I)C(NCC(CO)O)=O)I)I)CO AJJNAAOMSHXOKI-UHFFFAOYSA-N 0.000 description 3
IRIRHXXUSZTSTF-UHFFFAOYSA-N 6-amino-2,2-dimethyl-1,3-dioxepin-5-ol Chemical group CC1(C)OC=C(N)C(O)=CO1 IRIRHXXUSZTSTF-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
YYOZBIVIVJCBLC-UHFFFAOYSA-N [3-acetyloxy-1,4-bis(3,5-dicarbonochloridoyl-2,4,6-triiodo-N-methylanilino)-1,4-dioxobutan-2-yl] acetate Chemical compound ClC(=O)C=1C(=C(N(C(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(=O)Cl)I)C(=O)Cl)I)C)OC(C)=O)OC(C)=O)=O)C)C(=C(C=1I)C(=O)Cl)I)I YYOZBIVIVJCBLC-UHFFFAOYSA-N 0.000 description 3
125000002252 acyl group Chemical group 0.000 description 3
238000007112 amidation reaction Methods 0.000 description 3
238000002583 angiography Methods 0.000 description 3
239000013078 crystal Substances 0.000 description 3
239000000539 dimer Substances 0.000 description 3
238000010253 intravenous injection Methods 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 3
YBJUQFREFLSALI-UHFFFAOYSA-N (1,3-dichloro-1,3-dioxopropan-2-yl) acetate Chemical compound CC(=O)OC(C(Cl)=O)C(Cl)=O YBJUQFREFLSALI-UHFFFAOYSA-N 0.000 description 2
FCKXGFANXSHGAW-DTXPUJKBSA-N (2s)-n,n'-bis[(2s)-1-(2-chloro-4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]-2-hydroxybutanediamide Chemical compound C([C@H](NC(=O)C[C@H](O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NC=1C(=CC(=CC=1)[N+]([O-])=O)Cl)C(=O)NC=1C(=CC(=CC=1)[N+]([O-])=O)Cl)C1=CC=CC=C1 FCKXGFANXSHGAW-DTXPUJKBSA-N 0.000 description 2
SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 2
JRNWXOLVRYJKSU-UHFFFAOYSA-N 2-phenylmethoxypropanedioyl dichloride Chemical compound ClC(=O)C(C(Cl)=O)OCC1=CC=CC=C1 JRNWXOLVRYJKSU-UHFFFAOYSA-N 0.000 description 2
ZHFSEYDWIIBDBF-UHFFFAOYSA-N 5-[[3-(3,5-dicarbonochloridoyl-2,4,6-triiodo-N-methylanilino)-2-methoxy-3-oxopropanoyl]-methylamino]-2,4,6-triiodobenzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(=O)Cl)I)C(=O)Cl)I)C)OC)=O)C)C(=C(C=1I)C(=O)Cl)I)I ZHFSEYDWIIBDBF-UHFFFAOYSA-N 0.000 description 2
KNPKVJCZAFAXNP-UHFFFAOYSA-N 5-[[3-(3,5-dicarbonochloridoyl-2,4,6-triiodo-N-methylanilino)-3-oxo-2-phenylmethoxypropanoyl]-methylamino]-2,4,6-triiodobenzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(=O)Cl)I)C(=O)Cl)I)C)OCC2=CC=CC=C2)=O)C)C(=C(C=1I)C(=O)Cl)I)I KNPKVJCZAFAXNP-UHFFFAOYSA-N 0.000 description 2
QZGZYOQQNDDMFS-UHFFFAOYSA-N 5-[[3-[3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodoanilino]-2-hydroxy-3-oxopropanoyl]amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OC(CNC(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(NCC(CO)O)=O)I)C(NCC(CO)O)=O)I)O)=O)C(=C(C=1I)C(NCC(CO)O)=O)I)I)CO QZGZYOQQNDDMFS-UHFFFAOYSA-N 0.000 description 2
DLMVQJBXSJDWRX-UHFFFAOYSA-N 5-[[3-[3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodoanilino]-2-methoxy-3-oxopropanoyl]amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OC(CNC(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(NCC(CO)O)=O)I)C(NCC(CO)O)=O)I)OC)=O)C(=C(C=1I)C(NCC(CO)O)=O)I)I)CO DLMVQJBXSJDWRX-UHFFFAOYSA-N 0.000 description 2
PUUZWNRPBZIRQJ-UHFFFAOYSA-N 5-[[3-[3,5-bis[2,3-dihydroxypropyl(methyl)carbamoyl]-2,4,6-triiodoanilino]-2-hydroxy-3-oxopropanoyl]amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1-N,3-N-dimethylbenzene-1,3-dicarboxamide Chemical compound OC(CN(C(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(N(C)CC(CO)O)=O)I)C(N(C)CC(CO)O)=O)I)O)=O)C(=C(C=1I)C(N(C)CC(CO)O)=O)I)I)C)CO PUUZWNRPBZIRQJ-UHFFFAOYSA-N 0.000 description 2
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
239000005711 Benzoic acid Substances 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
206010028813 Nausea Diseases 0.000 description 2
ZPSLNDUPZXGBDU-UHFFFAOYSA-N OC(CN(C(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(N(C)CC(CO)O)=O)I)C(N(C)CC(CO)O)=O)I)C)O)=O)C)C(=C(C1I)C(N(C)CC(CO)O)=O)I)I)C)CO Chemical compound OC(CN(C(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(N(C)CC(CO)O)=O)I)C(N(C)CC(CO)O)=O)I)C)O)=O)C)C(=C(C1I)C(N(C)CC(CO)O)=O)I)I)C)CO ZPSLNDUPZXGBDU-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
239000000370 acceptor Substances 0.000 description 2
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
125000004442 acylamino group Chemical group 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
235000010233 benzoic acid Nutrition 0.000 description 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
238000009835 boiling Methods 0.000 description 2
GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
230000002604 chemotoxic effect Effects 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
230000008693 nausea Effects 0.000 description 2
239000002798 polar solvent Substances 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
YONLFQNRGZXBBF-ZIAGYGMSSA-N (2r,3r)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 description 1
HIFJACZLIZHJFC-UHFFFAOYSA-N (3-acetyloxy-1,4-dichloro-1,4-dioxobutan-2-yl) acetate Chemical compound CC(=O)OC(C(Cl)=O)C(C(Cl)=O)OC(C)=O HIFJACZLIZHJFC-UHFFFAOYSA-N 0.000 description 1
LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
QFFFXGJRVBTPCW-UHFFFAOYSA-N 1-bromopropane-1,1-diol Chemical compound CCC(O)(O)Br QFFFXGJRVBTPCW-UHFFFAOYSA-N 0.000 description 1
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
JJKWHOSQTYYFAE-UHFFFAOYSA-N 2-methoxyacetyl chloride Chemical compound COCC(Cl)=O JJKWHOSQTYYFAE-UHFFFAOYSA-N 0.000 description 1
OIFKZHWSLBKFTN-UHFFFAOYSA-N 2-methoxypropanedioyl dichloride Chemical compound COC(C(Cl)=O)C(Cl)=O OIFKZHWSLBKFTN-UHFFFAOYSA-N 0.000 description 1
KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 description 1
SSZWWUDQMAHNAQ-UHFFFAOYSA-N 3-chloropropane-1,2-diol Chemical compound OCC(O)CCl SSZWWUDQMAHNAQ-UHFFFAOYSA-N 0.000 description 1
ZFYPEIYUTKIERU-UHFFFAOYSA-N 5-[[2-hydroxy-3-oxo-3-[2,4,6-triiodo-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-2,4,6-triiodo-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide Chemical compound OC(C(CO)NC(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(NC(C(CO)O)CO)=O)I)C(NC(C(CO)O)CO)=O)I)O)=O)C(=C(C=1I)C(NC(C(CO)O)CO)=O)I)I)CO ZFYPEIYUTKIERU-UHFFFAOYSA-N 0.000 description 1
DQRUBWGUPRFIPB-UHFFFAOYSA-N 5-[[2-hydroxy-3-oxo-3-[2,4,6-triiodo-N-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]-methylamino]-2,4,6-triiodo-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide Chemical compound OC(C(CO)NC(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(NC(C(CO)O)CO)=O)I)C(NC(C(CO)O)CO)=O)I)C)O)=O)C)C(=C(C=1I)C(NC(C(CO)O)CO)=O)I)I)CO DQRUBWGUPRFIPB-UHFFFAOYSA-N 0.000 description 1
KLIHQSKYVHMUEF-UHFFFAOYSA-N 5-[[3-(3,5-dicarbonochloridoyl-2,4,6-triiodoanilino)-3-oxo-2-phenylmethoxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(=O)Cl)I)C(=O)Cl)I)OCC2=CC=CC=C2)=O)C(=C(C=1I)C(=O)Cl)I)I KLIHQSKYVHMUEF-UHFFFAOYSA-N 0.000 description 1
WKYNJECGANCXBR-UHFFFAOYSA-N 5-[[3-[3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodo-N-methylanilino]-2-hydroxy-3-oxopropanoyl]-methylamino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OC(CNC(=O)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(NCC(CO)O)=O)I)C(NCC(CO)O)=O)I)C)O)=O)C)C(=C(C=1I)C(NCC(CO)O)=O)I)I)CO WKYNJECGANCXBR-UHFFFAOYSA-N 0.000 description 1
KTXBFQYWIYFEGW-UHFFFAOYSA-N 5-[[4-[3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodo-N-methylanilino]-2,3-dihydroxy-4-oxobutanoyl]-methylamino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OC(CNC(=O)C=1C(=C(N(C(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(NCC(CO)O)=O)I)C(NCC(CO)O)=O)I)C)O)O)=O)C)C(=C(C=1I)C(NCC(CO)O)=O)I)I)CO KTXBFQYWIYFEGW-UHFFFAOYSA-N 0.000 description 1
UHRUNEYTTKLQDE-UHFFFAOYSA-N 6-[[3-[[5,6-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodocyclohexa-2,4-dien-1-yl]amino]-2-methoxy-3-oxopropanoyl]amino]-1-N,2-N-bis(2,3-dihydroxypropyl)-1,3,5-triiodocyclohexa-2,4-diene-1,2-dicarboxamide Chemical compound OC(CNC(=O)C1(C(NC(C(C(=O)NC2C(C(=C(C=C2I)I)C(NCC(CO)O)=O)(I)C(NCC(CO)O)=O)OC)=O)C(=CC(=C1C(NCC(CO)O)=O)I)I)I)CO UHRUNEYTTKLQDE-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
208000009079 Bronchial Spasm Diseases 0.000 description 1
208000014181 Bronchial disease Diseases 0.000 description 1
206010006482 Bronchospasm Diseases 0.000 description 1
GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
208000010496 Heart Arrest Diseases 0.000 description 1
206010020852 Hypertonia Diseases 0.000 description 1
206010061216 Infarction Diseases 0.000 description 1
NURLJCQMXRSLBN-UHFFFAOYSA-N N,N'-bis[3,5-bis(1,3-dihydroxypropan-2-yl)-2,4,6-triiodophenyl]-2-hydroxy-N,N'-dimethylpropanediamide Chemical compound OCC(CO)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(CO)CO)I)C(CO)CO)I)C)O)=O)C)C(=C(C=1I)C(CO)CO)I)I NURLJCQMXRSLBN-UHFFFAOYSA-N 0.000 description 1
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
238000007126 N-alkylation reaction Methods 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
XDRAONKRHGWFTC-UHFFFAOYSA-N OC(C(O)N(C(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(N(C(C(CO)O)O)C)=O)I)C(N(C(C(CO)O)O)C)=O)I)O)=O)C(=C(C1I)C(N(C(C(CO)O)O)C)=O)I)I)C)CO Chemical compound OC(C(O)N(C(=O)C=1C(=C(NC(C(C(=O)NC2=C(C(=C(C(=C2I)C(N(C(C(CO)O)O)C)=O)I)C(N(C(C(CO)O)O)C)=O)I)O)=O)C(=C(C1I)C(N(C(C(CO)O)O)C)=O)I)I)C)CO XDRAONKRHGWFTC-UHFFFAOYSA-N 0.000 description 1
CGQKZHQAUCCXAC-UHFFFAOYSA-N OCC(CO)C(C(I)=C(C(I)=C1C(CO)CO)NC(C(C(NC(C(I)=C(C(CO)CO)C(I)=C2C(CO)CO)=C2I)=O)OCC2=CC=CC=C2)=O)=C1I Chemical compound OCC(CO)C(C(I)=C(C(I)=C1C(CO)CO)NC(C(C(NC(C(I)=C(C(CO)CO)C(I)=C2C(CO)CO)=C2I)=O)OCC2=CC=CC=C2)=O)=C1I CGQKZHQAUCCXAC-UHFFFAOYSA-N 0.000 description 1
FAVYARSTWSBMBF-UHFFFAOYSA-N OCC(CO)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(CO)CO)I)C(CO)CO)I)CCO)O)=O)CCO)C(=C(C=1I)C(CO)CO)I)I Chemical compound OCC(CO)C=1C(=C(N(C(C(C(=O)N(C2=C(C(=C(C(=C2I)C(CO)CO)I)C(CO)CO)I)CCO)O)=O)CCO)C(=C(C=1I)C(CO)CO)I)I FAVYARSTWSBMBF-UHFFFAOYSA-N 0.000 description 1
YMQOSNGWNHHAIW-UHFFFAOYSA-N OCC(CO)C=1C(=C(NC(C(C(C(=O)NC2=C(C(=C(C(=C2I)C(CO)CO)I)C(CO)CO)I)O)O)=O)C(=C(C1I)C(CO)CO)I)I Chemical compound OCC(CO)C=1C(=C(NC(C(C(C(=O)NC2=C(C(=C(C(=C2I)C(CO)CO)I)C(CO)CO)I)O)O)=O)C(=C(C1I)C(CO)CO)I)I YMQOSNGWNHHAIW-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
XYQRXRFVKUPBQN-UHFFFAOYSA-L Sodium carbonate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]C([O-])=O XYQRXRFVKUPBQN-UHFFFAOYSA-L 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
XXFXTBNFFMQVKJ-UHFFFAOYSA-N [diphenyl(trityloxy)methyl]benzene Chemical group C=1C=CC=CC=1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)OC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XXFXTBNFFMQVKJ-UHFFFAOYSA-N 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
125000004423 acyloxy group Chemical group 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
230000009435 amidation Effects 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
150000001491 aromatic compounds Chemical class 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
230000036471 bradycardia Effects 0.000 description 1
208000006218 bradycardia Diseases 0.000 description 1
150000001649 bromium compounds Chemical class 0.000 description 1
RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
239000000872 buffer Substances 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
JHECKPXUCKQCSH-UHFFFAOYSA-J calcium;disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate;hydrate Chemical compound O.[Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O JHECKPXUCKQCSH-UHFFFAOYSA-J 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
229920001429 chelating resin Polymers 0.000 description 1
150000001805 chlorine compounds Chemical class 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
230000007423 decrease Effects 0.000 description 1
238000011033 desalting Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical class C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
229940008406 diethyl sulfate Drugs 0.000 description 1
SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
125000004185 ester group Chemical group 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
125000001033 ether group Chemical group 0.000 description 1
238000001914 filtration Methods 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
230000000004 hemodynamic effect Effects 0.000 description 1
GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
150000004678 hydrides Chemical class 0.000 description 1
125000002768 hydroxyalkyl group Chemical group 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000007574 infarction Effects 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000005304 joining Methods 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
229940102396 methyl bromide Drugs 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
150000002763 monocarboxylic acids Chemical class 0.000 description 1
238000009608 myelography Methods 0.000 description 1
PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
235000011837 pasties Nutrition 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
238000011849 radiological investigation Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000007127 saponification reaction Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000035939 shock Effects 0.000 description 1
229940001593 sodium carbonate Drugs 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
229940018038 sodium carbonate decahydrate Drugs 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
229940037001 sodium edetate Drugs 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000000725 suspension Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
210000001635 urinary tract Anatomy 0.000 description 1
238000007487 urography Methods 0.000 description 1
230000002792 vascular Effects 0.000 description 1
230000008673 vomiting Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Polyesters Or Polycarbonates (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO885093A 1987-11-16 1988-11-15 Nye substituerte dicarboxylsyre-bis(3,5-dicarbamoyl)-2,4,6-trijod-anilider, og röntgenkontrastmidler inneholdende disse NO175858C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19873739098 DE3739098A1 (de)	1987-11-16	1987-11-16	Neue substituierte dicarbonsaeure-bis(3,5-dicarbamoyl-2,4,6- trijod-anilide), verfahren zu deren herstellung sowie diese enthaltende roentgenkontrastmittel

Publications (4)

Publication Number	Publication Date
NO885093D0 NO885093D0 (no)	1988-11-15
NO885093L NO885093L (no)	1989-05-18
NO175858B true NO175858B (pt)	1994-09-12
NO175858C NO175858C (no)	1994-12-21

Family

ID=6340719

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO885093A NO175858C (no)	1987-11-16	1988-11-15	Nye substituerte dicarboxylsyre-bis(3,5-dicarbamoyl)-2,4,6-trijod-anilider, og röntgenkontrastmidler inneholdende disse

Country Status (14)

Country	Link
US (1)	US5004835A (pt)
EP (1)	EP0317492B1 (pt)
JP (1)	JP2553170B2 (pt)
KR (1)	KR970011452B1 (pt)
AT (1)	ATE106385T1 (pt)
AU (1)	AU614310B2 (pt)
DE (2)	DE3739098A1 (pt)
DK (1)	DK638088A (pt)
ES (1)	ES2053796T3 (pt)
FI (1)	FI93209C (pt)
IE (1)	IE64759B1 (pt)
NO (1)	NO175858C (pt)
PT (1)	PT89004B (pt)
ZA (1)	ZA888571B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3731542A1 (de) *	1987-09-17	1989-03-30	Schering Ag	Neue dicarbonsaeure-bis(3,5-dicarbamoyl-2,4,6-triiod-anilide), verfahren zu deren herstellung sowie diese enthaltende roentgenkontrastmittel
IL94718A (en) *	1989-07-05	1994-10-21	Schering Ag	Non-ionic carboxamide contrast agent and method of preparation
US5075502A (en) *	1989-12-13	1991-12-24	Mallinckrodt, Inc.	Nonionic x-ray contrast agents, compositions and methods
ES2037605B1 (es) *	1991-11-18	1994-02-01	Invest Justesa Imagen S A Cent	Metodo para preparar nuevos agentes yodados no ionicos de constraste a los rayos x.
IT1252180B (it) *	1991-12-10	1995-06-05	Bracco Ind Chimica Spa	5,5'-(1,3-propandiil) bis (imino (2-osso-2,1-etandiil)acetilimino)-bis(2,4,6-triiodo-1,3-benzendicarbossiamidi),loro metodo di preparazione e mezzi di contrasto roentgenografici che li contengono
DE69308839T2 (de) *	1992-05-15	1997-07-24	Mallinckrodt Medical Inc	Verbesserte ioversol-synthese
WO1994022810A1 (es) *	1993-04-01	1994-10-13	Centro Investigacion Justesa Imagen, S.A.	Nuevos dimeros iodados no ionicos como agentes de contraste a los rayos x, metodo para su preparacion y composiciones galenicas que los contienen
US5611342A (en) *	1994-02-15	1997-03-18	Molecular Biosystems, Inc.	Method of computer tomography imaging the gastrointestinal tract and surrounding upper abdominal tissues and organs using an orally administered low density contrast medium
WO1995026331A1 (es) *	1994-03-25	1995-10-05	Centro Investigacion Justesa Imagen, S.A.	Nuevos dimeros iodados no ionicos como agentes de contraste a los rayos x, metodo para su preparacion y composiciones farmaceuticas que los contienen
WO2012136813A2 (en)	2011-04-07	2012-10-11	Universitetet I Oslo	Agents for medical radar diagnosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2628517C2 (de) *	1976-06-23	1985-02-21	Schering AG, 1000 Berlin und 4709 Bergkamen	Dicarbonsäure-bis(3,5-dicarbamoyl-2,4,6-trijodanilid)-Verbindungen, Verfahren zu ihrer Herstellung und Röntgenkontrastmittel
IT1207226B (it) *	1979-08-09	1989-05-17	Bracco Ind Chimica Spa	Derivati dell'acido 2,4,6-triiodo-isoftalico, metodo per la loro preparazione e mezzi di contrasto che li contengono.
DE3038853A1 (de) *	1980-10-10	1982-05-27	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Neue n-hydroxy-alkylierte dicarbonsaeure-bis-(3,5-dicarbamoyl-2,4,6-trijodanilide), deren herstellung und diese enthaltende roentgenkonstrastmittel (ii)
EP0108638B1 (en) *	1982-11-08	1986-07-16	NYEGAARD & CO. A/S	X-ray contrast agents
DE3731542A1 (de) *	1987-09-17	1989-03-30	Schering Ag	Neue dicarbonsaeure-bis(3,5-dicarbamoyl-2,4,6-triiod-anilide), verfahren zu deren herstellung sowie diese enthaltende roentgenkontrastmittel

1987
- 1987-11-16 DE DE19873739098 patent/DE3739098A1/de not_active Ceased
1988
- 1988-11-11 DE DE3889863T patent/DE3889863D1/de not_active Expired - Lifetime
- 1988-11-11 ES ES88730249T patent/ES2053796T3/es not_active Expired - Lifetime
- 1988-11-11 EP EP88730249A patent/EP0317492B1/de not_active Expired - Lifetime
- 1988-11-11 AT AT88730249T patent/ATE106385T1/de active
- 1988-11-15 KR KR1019880014989A patent/KR970011452B1/ko not_active IP Right Cessation
- 1988-11-15 PT PT89004A patent/PT89004B/pt not_active IP Right Cessation
- 1988-11-15 DK DK638088A patent/DK638088A/da not_active Application Discontinuation
- 1988-11-15 IE IE341488A patent/IE64759B1/en not_active IP Right Cessation
- 1988-11-15 NO NO885093A patent/NO175858C/no unknown
- 1988-11-15 US US07/271,464 patent/US5004835A/en not_active Expired - Fee Related
- 1988-11-16 FI FI885295A patent/FI93209C/fi not_active IP Right Cessation
- 1988-11-16 ZA ZA888571A patent/ZA888571B/xx unknown
- 1988-11-16 JP JP63287884A patent/JP2553170B2/ja not_active Expired - Lifetime
- 1988-11-16 AU AU25169/88A patent/AU614310B2/en not_active Ceased

Also Published As

Publication number	Publication date
NO885093L (no)	1989-05-18
FI93209C (fi)	1995-03-10
DK638088D0 (da)	1988-11-15
FI885295A (fi)	1989-05-17
JPH01153667A (ja)	1989-06-15
FI885295A0 (fi)	1988-11-16
DK638088A (da)	1989-05-17
JP2553170B2 (ja)	1996-11-13
AU2516988A (en)	1989-05-18
EP0317492A3 (en)	1990-07-11
DE3889863D1 (de)	1994-07-07
NO885093D0 (no)	1988-11-15
ATE106385T1 (de)	1994-06-15
ZA888571B (en)	1989-08-30
US5004835A (en)	1991-04-02
PT89004B (pt)	1993-02-26
PT89004A (pt)	1988-12-01
NO175858C (no)	1994-12-21
EP0317492B1 (de)	1994-06-01
ES2053796T3 (es)	1994-08-01
KR890008079A (ko)	1989-07-08
AU614310B2 (en)	1991-08-29
DE3739098A1 (de)	1989-05-24
EP0317492A2 (de)	1989-05-24
FI93209B (fi)	1994-11-30
IE883414L (en)	1990-05-15
KR970011452B1 (ko)	1997-07-11
IE64759B1 (en)	1995-09-06

Publication	Publication Date	Title
US5073362A (en)	1991-12-17	Dicarboxylic acid-bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) and x-ray contrast media containing them
JP5830589B2 (ja)	2015-12-09	造影剤
US4364921A (en)	1982-12-21	Novel triiodinated isophthalic acid diamides as nonionic X-ray contrast media
DK148783B (da)	1985-09-30	Triiodbenzenderivater til anvendelse som roentgenkontrastmidler og roentgenkontrastmidler indeholdende saadanne forbindelser
US5232685A (en)	1993-08-03	Nonionic x-ray contrast medium with high iodine content
CS221814B2 (en)	1983-04-29	Method of making the triamide of the acid of 2,4,6-triiodebenzen-1,3-5-tricarboxyle
NO175858B (pt)	1994-09-12
US5183654A (en)	1993-02-02	Nonionic x-ray contrast medium with high iodine content
US8066970B2 (en)	2011-11-29	Contrast agents
US20080267884A1 (en)	2008-10-30	Contrast Agents and Diagnostic Compositions Based on Iodine-Containing Cyanuric Acid Derivatives
JPH06345705A (ja)	1994-12-20	テトラヨードベンゼン誘導体